Notable Labs ROE 2013-2024 | NTBLQ
Current and historical return on equity (ROE) values for Notable Labs (NTBLQ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Notable Labs ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-06-30 |
$-0.01B |
$0.01B |
-76.92% |
| 2024-03-31 |
$-0.01B |
$0.01B |
-50.00% |
| 2023-12-31 |
$-0.01B |
$0.02B |
-55.56% |
| 2023-09-30 |
$0.01B |
$0.02B |
100.00% |
| 2023-06-30 |
$-0.00B |
$0.02B |
-44.44% |
| 2023-03-31 |
$-0.01B |
$0.02B |
-85.71% |
| 2022-12-31 |
$-0.01B |
$-0.04B |
-80.00% |
| 2022-09-30 |
$-0.04B |
$0.03B |
-96.73% |
| 2022-06-30 |
$-0.04B |
$0.03B |
-79.10% |
| 2022-03-31 |
$-0.03B |
$0.04B |
-69.04% |
| 2021-12-31 |
$-0.03B |
$0.05B |
-63.16% |
| 2021-09-30 |
$-0.03B |
$0.05B |
-65.88% |
| 2021-06-30 |
$-0.03B |
$0.05B |
-68.35% |
| 2021-03-31 |
$-0.03B |
$0.04B |
-68.03% |
| 2020-12-31 |
$-0.02B |
$0.03B |
-67.61% |
| 2020-09-30 |
$-0.02B |
$0.04B |
-62.59% |
| 2020-06-30 |
$-0.02B |
$0.04B |
-58.28% |
| 2020-03-31 |
$-0.02B |
$0.03B |
-54.90% |
| 2019-12-31 |
$-0.02B |
$0.04B |
-46.51% |
| 2019-09-30 |
$-0.02B |
$0.04B |
-38.10% |
| 2019-06-30 |
$-0.02B |
$0.05B |
-35.12% |
| 2019-03-31 |
$-0.02B |
$0.05B |
-30.77% |
| 2018-12-31 |
$-0.02B |
$0.05B |
-36.20% |
| 2018-09-30 |
$-0.01B |
$0.06B |
-17.86% |
| 2018-06-30 |
$-0.01B |
$0.06B |
-24.37% |
| 2018-03-31 |
$-0.01B |
$0.05B |
-30.41% |
| 2017-12-31 |
$-0.01B |
$0.06B |
-27.67% |
| 2017-09-30 |
$-0.02B |
$0.03B |
-60.69% |
| 2017-06-30 |
$-0.02B |
$0.04B |
-44.44% |
| 2017-03-31 |
$-0.02B |
$0.04B |
-36.36% |
| 2016-12-31 |
$-0.02B |
$0.04B |
-37.87% |
| 2016-09-30 |
$-0.01B |
$0.05B |
-34.57% |
| 2016-06-30 |
$-0.02B |
$0.05B |
-48.92% |
| 2016-03-31 |
$-0.02B |
$0.03B |
-56.67% |
| 2015-12-31 |
$-0.02B |
$0.04B |
-49.59% |
| 2015-09-30 |
$-0.02B |
$0.02B |
-56.20% |
| 2015-06-30 |
$-0.02B |
$0.03B |
-60.00% |
| 2015-03-31 |
$-0.02B |
$0.03B |
-91.43% |
| 2014-12-31 |
$-0.02B |
$0.04B |
-189.47% |
| 2014-06-30 |
$-0.01B |
$0.00B |
233.33% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
